UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 15, 2016

AMERICANN, INC.
(Exact name of registrant as specified in its charter)

3200 Brighton Blvd., Unit 144
                      Denver, CO 80216                    
(Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code: (303) 862-9000

                                                              
(Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below)

Item 8.01.     Other Events

Introduction of Solanna Line of Cannabis Infused Products

On September 21, 2016 the Company issued a press release announcing the creation of “Solanna”, a new, comprehensive line of nutraceutical-grade cannabis infused products. The intellectual property pertaining to Solanna will be licensed by the Company to regulated cannabis businesses.

A copy of the press release is attached as Exhibit 99.

Massachusetts Medical Cannabis Center

Previously the Company entered into an agreement to purchase a 52.6-acre parcel of undeveloped land in Freetown, Massachusetts. The property is located approximately 47 miles southeast of Boston. The Company plans to develop the property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC may include the construction of sustainable greenhouse cultivation, processing, and infused product facilities that will be leased or sold to Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

The Company paid the seller $100,000 upon the signing of the agreement which amount will be applied toward the purchase price of $4,000,000 at the closing. Pursuant to the original agreement the closing was to take place on or before June 1, 2015. On May 6, 2015, to address site considerations before finalizing the planned development, the agreement was amended to extend the closing date to September 1, 2015.  On August 27, 2015, after addressing the site considerations, the agreement was amended to extend the closing date to October 30, 2015 to provide additional time for permitting. In connection with this amendment, the Company paid the seller an additional $100,000. On October 23, 2015, the Company made an additional payment of $100,000 to extend the closing date to December 29, 2015. These payments of $300,000 will be applied to the purchase price.

On August 15, 2016 the Company and seller amended the Agreement for the eleventh time and extended the closing date to September 15, 2016. As consideration for the extension of the closing date, the Company agreed to increase the purchase price for the property to $4,400,000 and pay the seller $75,000 which will be applied to the purchase price if the closing occurs.

On September 15, 2016, the Company, at its election, extended the closing date to October 14, 2016 with an additional payment of $75,000 to the seller, which payment will be applied to the purchase price if the closing occurs. As a result of the extension of the closing date, the purchase price for the property increased to $4,475,000.

To date, the Company has paid the seller $925,000 that will be applied to the purchase price of the property if and when the Company closes on the transaction.

Item 9.01.          Financial Statements and Exhibits

Number                  Description

99                         Press Release

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 21, 2016

 4